VA awards $838K for Ortho Vision lease and reagents to QuidelOrtho Sales Company, LLC
Contract Overview
Contract Amount: $838,535 ($838.5K)
Contractor: Quidelortho Sales Company, LLC
Awarding Agency: Department of Veterans Affairs
Start Date: 2022-10-01
End Date: 2025-09-30
Contract Duration: 1,095 days
Daily Burn Rate: $766/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: LEASE OF ORTHO VISION AND REAGENTS
Place of Performance
Location: MEMPHIS, SHELBY County, TENNESSEE, 38104
Plain-Language Summary
Department of Veterans Affairs obligated $838,535.15 to QUIDELORTHO SALES COMPANY, LLC for work described as: LEASE OF ORTHO VISION AND REAGENTS Key points: 1. Contract awarded to a single vendor, QuidelOrtho Sales Company, LLC. 2. Spending is for analytical laboratory instruments and related reagents. 3. The contract duration is 3 years, ending September 30, 2025. 4. The award is a delivery order under a larger contract. 5. No small business participation is indicated.
Value Assessment
Rating: fair
The contract value of $838,535.15 over three years suggests a moderate annual spend. Benchmarking against similar analytical laboratory instrument leases would be necessary to fully assess pricing, but the firm fixed price structure provides cost certainty.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and ensures the government receives fair value.
Taxpayer Impact: The total award amount of $838,535.15 represents taxpayer funds allocated for essential laboratory equipment and supplies for the Department of Veterans Affairs.
Public Impact
Ensures VA medical facilities have necessary diagnostic equipment. Supports timely and accurate patient diagnoses through reagent supply. Potential impact on veterans' access to advanced medical testing.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Lack of specific small business participation noted.
- Limited detail on the competitive bidding process beyond 'full and open'.
Positive Signals
- Firm fixed price contract provides cost predictability.
- Awarded under full and open competition.
- Supports critical healthcare operations for veterans.
Sector Analysis
The spending falls within the Analytical Laboratory Instrument Manufacturing sector. Benchmarks for similar instrument leases and reagent contracts are crucial for evaluating cost-effectiveness, as prices can vary significantly based on technology and vendor.
Small Business Impact
The data indicates that this contract did not involve small business participation. Further investigation could explore if opportunities for small businesses were missed or if the nature of the requirement precluded their involvement.
Oversight & Accountability
The Department of Veterans Affairs is responsible for the oversight of this contract. Accountability would involve ensuring the leased equipment functions as specified and that reagents are delivered on time and meet quality standards.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Potential for vendor lock-in with specialized reagents.
- Reliance on a single supplier for critical diagnostic components.
- Lack of explicit small business subcontracting goals.
- Need for ongoing price benchmarking of reagents.
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, tn, delivery-order, 100k-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $838,535.15 to QUIDELORTHO SALES COMPANY, LLC. LEASE OF ORTHO VISION AND REAGENTS
Who is the contractor on this award?
The obligated recipient is QUIDELORTHO SALES COMPANY, LLC.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $838,535.15.
What is the period of performance?
Start: 2022-10-01. End: 2025-09-30.
What is the specific type of 'Ortho Vision' system being leased, and what are its key capabilities compared to alternative systems?
The 'Ortho Vision' system likely refers to an automated clinical diagnostics platform used for immunoassay testing. Its capabilities would typically include high-throughput sample processing, advanced detection methods, and integrated data management. A comparative analysis against alternative systems would assess factors like speed, accuracy, menu of tests, and ease of use to determine if the selected system offers optimal value and performance for the VA's specific needs.
How does the per-unit cost of reagents compare to market rates, considering the volume purchased under this contract?
Assessing the per-unit cost of reagents requires access to specific product codes and current market pricing. Given the contract's total value and duration, the VA is likely purchasing a significant volume. A comparison against benchmark pricing for similar reagent types from other suppliers or through GSA schedules would reveal if the negotiated prices reflect volume discounts and competitive market rates, or if there is potential for cost savings.
What performance metrics are tracked for the Ortho Vision system, and how has it performed against these metrics since the contract's start date?
Performance metrics for leased laboratory equipment typically include uptime, turnaround time for tests, error rates, and maintenance response times. Tracking these metrics is crucial for ensuring the system meets the VA's operational demands and provides reliable diagnostic support. A review of performance reports and any service calls logged would indicate the system's effectiveness and the vendor's responsiveness, highlighting any potential issues impacting patient care or workflow efficiency.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 9975 SUMMERS RIDGE RD, SAN DIEGO, CA, 92121
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $1,263,361
Exercised Options: $838,535
Current Obligation: $838,535
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: V797D60637
IDV Type: FSS
Timeline
Start Date: 2022-10-01
Current End Date: 2025-09-30
Potential End Date: 2025-09-30 00:00:00
Last Modified: 2026-04-07
More Contracts from Quidelortho Sales Company, LLC
- ::blood Bank Analyzer:: — $172.7K (Department of Veterans Affairs)
- Blood Bank Testing Quality Control for Boise VA Medical Center — $66.1K (Department of Veterans Affairs)
- Blook Bank Testing Supplies — $45.2K (Department of Veterans Affairs)
- Quidelorthro Triage Meterpro Reagents and Supplies — $40.8K (Department of Veterans Affairs)
- Ortho Clinical BPA Call Against 75H70621A00009; Srsu/Fyh — $33.0K (Department of Health and Human Services)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)